Lincare
Lincare a leading supplier of respiratory-therapy products & services for patients at home
Based in FL
🤖
AI Overview
With $2.6M in lobbying spend across 32 quarterly filings, Lincare is a significant lobbying presence. They deploy 12 individual lobbyists
$2.6M
Total Lobbying Spend
32
Quarterly Filings
1
Lobbying Firms Used
12
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $320K |
| 2019 | $320K |
| 2020 | $320K |
| 2021 | $320K |
| 2022 | $400K |
| 2023 | $320K |
| 2024 | $240K |
| 2025 | $320K |
Lobbying Firms
TARPLIN, DOWNS & YOUNG, LLC
What They Lobby For
- coverage and reimbursement, respiratory issues
- H.R. 1625 - Consolidated Appropriations Act of 2018 H.R. 1892 - Bipartisan Budget Act of 2018
- Competitive Bidding Medicare coverage and reimbursement Diagnostics
- Competitive Bidding, durable medical equipment Medicare coverage and reimbursement Diagnostics Self-testing, home care
- H.R. 1625 - Consolidated Appropriations Act of 2018 H.R. 1892 - Bipartisan Budget Act of 2018 2019 Appropriations
- H.R. 1625 - Consolidated Appropriations Act of 2018 H.R. 1892 - Bipartisan Budget Act of 2018 H.R. 6157 - HHS appropriations and continuing resolution
- H.R. 1625 - Consolidated Appropriations Act of 2018 H.R. 1892 - Bipartisan Budget Act of 2018 H.R. 6157 - HHS appropriations and continuing resolution H.R. 695 - Department of Defense Appropriations Act
- Competitive Bidding, durable medical equipment Medicare coverage and reimbursement Diagnostics INR Self-testing, home care
- H.J.Res. 31 - Consolidated Appropriations Act, 2019
- H.R. 2740 - HHS Appropriations, 2020
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.